Showing results (3601-3610 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|February 14, 2018
A Phase I Dose-Escalation Study of Clofarabine in Patients with Relapsed or Refractory Low-Grade or Intermediate-Grade B-Cell or T-Cell LymphomaFrancine Marie Foss, Terri Parker
The Oncologist|February 14, 2018
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First-Line Nonsquamous Non-Small Cell Lung CancerJoachim von Pawel, David R Spigel, Thomas Ervin, et al.
The Oncologist|February 14, 2018
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E MutationsLauretta Odogwu, Luckson Mathieu, Gideon Blumenthal, et al.
The Oncologist|January 27, 2018
Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer MonitoringRuth Perets, Orli Greenberg, Talia Shentzer, et al.
The Oncologist|January 27, 2018
Prospective Evaluation of the Impact of the 21-Gene Recurrence Score Assay on Adjuvant Treatment Decisions for Women with Node-Positive Breast Cancer in Ontario, CanadaSofia Torres, Maureen Trudeau, Sonal Gandhi, et al.
The Oncologist|January 27, 2018
Serious Illness Conversations: Paving the Road with MetaphorsDavid Hui, Donna S Zhukovsky, Eduardo Bruera
The Oncologist|February 2, 2018
Early Gastric Cancer: Clinical Behavior and Treatment Options. Results of an Italian Multicenter Study on Behalf of the Italian Gastric Cancer Research Group (GIRCG)Luca Saragoni, Emanuela Scarpi, Alessandra Ravaioli, et al.
The Oncologist|February 2, 2018
Benefit-Risk Summary of Regorafenib for the Treatment of Patients with Advanced Hepatocellular Carcinoma That Has Progressed on SorafenibLorraine Pelosof, Steven Lemery, Sandra Casak, et al.
The Oncologist|January 11, 2018
Fertility-Sparing Treatment of Endometrial Cancer with Initial Infiltration of Myometrium by Resectoscopic Surgery: A Pilot StudyPaolo Casadio, Francesca Guasina, Roberto Paradisi, et al.
The Oncologist|January 11, 2018
Safety Profile of Biosimilar Filgrastim (Zarzio/Zarxio): A Combined Analysis of Phase III StudiesNadia Harbeck, Pere Gascón, Andriy Krendyukov, et al.
Pageof 571